Given the absence of an in vitro PD model for the enteric nervous system, the PrP-A53T Line G2-3 model was chosen for its relevance to synucleinopathy and because it is the only known model developing gastrointestinal dysfunctions [34,55]. Here, PRNP is linked to Parkinson disease.